Seqens Lahr
Our Lahr site is dedicated to the manufacture of APIs and pharmaceutical intermediates. It is GMP-certified and has been awarded the gold medal in the EcoVadis CRS ranking for 2022. The last inspection by the authorities took place on December 2, 2022. The main technologies used on the site are: hydrogenation, reductive amination, organometallic reactions, carbonylation and hydroformylation, enantiopure synthesis...
Bu
Bureau
Informations
Business line
Fabrication à façon, API, Intermédiaires
Surface
48, 000 M²
LAB Surface
700 M²
Capabilities
Total reactor capacity: 92 m³
- Reaction vessels: 1 to 6 300 L; temperature -80°C to +250 °C
- Multi-purpose state of the art cGMP facilty: 4 independent, vertical integrated production trains 800 L train, 2 x 3 000 L trains plus 1 x 3 000 L low temperature hydrogenation reactor and 6 000 L train
- Classic two-floor layout Facility: 20 vessels with capacity between 800 and 6 000 L (glaslined and SS)
- Autoclaves (operational range up to 100 bar)
- Kilo-Lab: 3 reactors: 25 / 100 / 250 L
Flagships Technologies
Hy
Hydrogenation
Hydrogenation
Re
Reductive
Reductive amination
Or
Organometallic
Organometallic reactions
Pr
Protected
Protected AADs (Aminoacid derivatives)
Ca
Carbonylation
Carbonylation and Hydroformylation
Pr
Pressure
Pressure aminolysis, other reactions under pressure
Cr
Cryogenic
Cryogenic chemistry
En
Enantiopure
Enantiopure synthesis
Cy
Cyanation
Cyanation high volumes (NaCN) C-C coupling
Re
Reductions
Reductions
Ha
Halogenation
Halogenation